Massive Ascites Associated with All-trans Retinoic Acid Treatment in Therapy-Related Acute Promyelocytic Leukemia
スポンサーリンク
概要
- 論文の詳細を見る
A 77-year-old man who developed pancytopenia was administered granulocyte colony-stimulating factor (G-CSF) by another doctor, and referred to us for the evaluation of pancytopenia. He had hepatocellular carcinoma and was treated with transcatheter arterial chemoembolization (TACE) containg epirubicin (total dose: 300 mg over the last two years). Bone marrow aspiration smear demonstrated hypercellular marrow with promyelocytes. Cytogenetic analysis demonstrated del(7), t(15;17)(q22;q12), and a fluorescence in-situ hybridization (FISH) study demonstrated chimeric fusion genes of PML-RAR-α. He was diagnosed with therapy-related acute promyelocytic leukemia (APL), and treated with all trans-retinoic acid (ATRA). He showed the progressive accumulation of ascites with liver damage, without pulmonary symptoms of ATRA differentiation syndrome. After 60 days of ATRA treatment, complete hematological and cytogenetic responses were achieved. However, the patient died of septic circulatory failure.
著者
-
Suzukawa Munehiro
Division of Hematology, Department of Medicine, Yamaguchi Prefectural Medical Center
-
Nakazora Tatsuki
Division of Hematology, Department of Medicine, Yamaguchi Prefectural Medical Center
-
Kawasaki Yasufumi
Division of Hematology, Department of Medicine, Yamaguchi Prefectural Medical Center
-
Tominaga Takayuki
Division of Hematology, Department of Medicine, Yamaguchi Prefectural Medical Center
-
Shinohara Kenji
Division of Hematology, Department of Medicine, Yamaguchi Prefectural Medical Center
-
Shinohara Kenji
Division of Environment and Radiation Science, Nuclear Science and Energy Directions, Japan Atomic Energy Agency
関連論文
- Massive Ascites Associated with All-trans Retinoic Acid Treatment in Therapy-Related Acute Promyelocytic Leukemia
- Transient Severe Pancytopenia due to Elevated Tumor Necrosis Factor-α in Overwhelming Infection
- A case of factor X (FX) deficiency due to novel mutation V196M, FX Hofu
- Morphological and Cytogenetic Changes in Therapy-Related Leukemia Developed in a t(8;21)-Acute Myeloid Leukemia (M2) Patient: Sequential Cytogenetic and Molecular Analyses
- A case of therapy-related acute myeloblastic leukemia with t(16;21)(q24;q22) after chemotherapy with DNA-topoisomerase II inhibitors, ,etoposide and mitoxantrone, and the alkylating agent, cyclophosphamide
- Therapy-Related Myelodysplastic Syndrome in a Case of Cutaneous Adult T-Cell Lymphoma
- Remission of Acute Myeloblastic Leukemia After Severe Pnemonia Treated With High-Dose Methylprednisolone
- Gamma/Delta T Cell Lymphoma
- Two Cases of Acute Myeloblastic Leukemia Evolving from Aplastic Anemia
- Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer
- Increased levels of soluble Fas antigen in the plasma of the patients with refractory anemia
- Two Patients in a Family with Unstable Hemoglobin, Hb Hirosaki : Anemia Was Ameliorated but Hemolysis Persists after Splenectomy
- Fever, Leukopenia and Autoantibody Complications in a Patient with Silicosis Successfully Treated with Prednisolone
- Propylthiouracil (PTU)-Induced Vasculitis Associated with Antineutrophil Antibody Against Myeloperoxidase (MPO-ANCA)
- Overuse of Granulocyte Colony-Stimulating Factor in Acute Myeloid Leukemia, Aplastic Anemia and Myelodysplastic Syndrome
- Acute Myeloblastic Leukemia in a Patient with Hereditary Protein C Deficiency
- Sarcoidosis Acutely Involving the Musculoskeletal System
- Angioimmunoblastic T Cell Lymphoma Associated with Reversible Myelofibrosis